The mean follow-up on-treatment was 181 days (median 155 days, IQR 71 to 290 days) for tirzepatide initiators and 174 days (median 148 days, IQR 82 to 254 days) for semaglutide initiators
GLP-1 can induce the expression of FNDC5 in pancreatic -cells through the interaction of its downstream transcription factor cAMP-response element binding protein (CREB) with binding elements in the FNDC5 promoter, thereby promoting the conversion of WAT to BAT and enhancing energy metabolism [85]
Neuroprotective strategies in neonatal brain injury
Funding Supported by the CounterACT Program, National Institutes of Health Office of the Director (NIH OD) and the National Institute of Environmental Health Sciences (NIEHS) grant number R21ES030528
Kidney transplant patients taking semaglutide have not demonstrated accelerated graft rejection or worsening kidney function in published case series and small observational studies, provided baseline kidney function is preserved
Medication Timing Try shifting the timing of your dose around predictable daily patterns, for example, aligning it with a sleep block or a light meal, then observe which slot produces fewer symptoms